Several companies reported their first-quarter financial results, reflecting varied performance across sectors. Lupin posted a 52.1% year-on-year increase in net profit to ₹1,219 crore, with revenue rising 11.9% to ₹6,268 crore and EBITDA up 39.2% to ₹1,727 crore, improving its margin to 27.6% from 22.2%. Gland Pharma's consolidated net profit surged nearly 50% to ₹215.5 crore, with revenue up 7.4% to ₹1,505.6 crore. Eid Parry reported a consolidated profit increase from ₹91 crore to ₹246 crore, revenue rose to ₹8,724 crore from ₹6,747 crore, and EBITDA margin improved to 9.2% from 7.2%. Uno Minda saw net profit rise 46.6% to ₹291 crore and revenue increase 17.6% to ₹4,489 crore. Bajaj Auto reported a 5.4% rise in adjusted PAT to ₹2,096 crore and revenue growth of 5.5% to ₹12,584 crore. Bayer's Q2 earnings showed sales of €10.74 billion, adjusted EBITDA of €2.11 billion with a margin of 19.6% exceeding estimates, and core EPS of €1.23. Bayer Crop's Q1 net profit increased 9.6% to ₹278.7 crore, with revenue up 17.4% to ₹1,914.6 crore. Market reactions included a 2% rise in Adani Ports shares, a 3% decline in Berger Paints, and an 8.5% gain in EPL shares following their Q1 results. The Nifty Pharma index declined 1.5%, led by falls in Granules and Biocon. Sarda Energy & Minerals shares surged 38% over three days post-Q1 results. Indian stocks opened negatively amid weak global cues and anticipation of the Reserve Bank of India's monetary policy committee decision.